- Home
- UNCY vs CSHRW Comparison
UNCY vs CSHRW Comparison
Compare UNCY & CSHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.75
Company Overview
Basic Information| Metric | UNCY | CSHRW |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Jersey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 167.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UNCY | CSHRW |
|---|---|---|
| Price | $5.75 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.67 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 7.4K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $582.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $0.59 |
| 52 Week High | $8.74 | $1.15 |
Technical Indicators
Market Signals| Indicator | UNCY | CSHRW |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 28.99 |
| Support Level | $4.11 | $0.59 |
| Resistance Level | $7.48 | $0.88 |
| Average True Range (ATR) | 0.79 | 0.15 |
| MACD | -0.23 | -0.03 |
| Stochastic Oscillator | 38.88 | 36.36 |
Price Performance
Historical Comparison UNCY
CSHRW
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.